US2008319173A1PendingUtilityA1
Blood group antigen fusion polypeptides and methods of use thereof
Est. expiryJul 20, 2021(expired)· nominal 20-yr term from priority
A61P 39/00A61P 37/06C07K 2319/00Y10S530/866C07K 2319/30A61K 38/1709C07K 14/4727
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides compositions and methods for treating or preventing antibody mediated graft rejection.
Claims
exact text as granted — not AI-modified1 . An absorber comprising a fusion polypeptide, wherein the fusion polypeptide comprises a first polypeptide operably linked to a second polypeptide, wherein the first polypeptide:
(a) is a mucin polypeptide and (b) is glycosylated by an α1,2 fucosyltransferase and the second polypeptide comprises at least a region of an immunoglobulin polypeptide.
2 . A method removing an antibody from a biological sample, the method comprising
(a) contacting a biological sample with the absorber of claim 1 to form an absorber-antibody complex; and (b) removing the complex from the biological sample thereby removing the antibody from the biological sample.Join the waitlist — get patent alerts
Track US2008319173A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.